[Isolation and determination of activity of IgA1 protease from Neisseria meningitidis].

Bioorganicheskaia khimiia Pub Date : 2010-01-01
E Iu Iagudaeva, L S Zhigis, O A Razguliaeva, V S Zueva, E E Mel'nikov, V P Zubov, L V Kozlov, A M Bichucher, O V Kotel'nikova, A P Alliluev, A E Avakov, L D Rumsh
{"title":"[Isolation and determination of activity of IgA1 protease from Neisseria meningitidis].","authors":"E Iu Iagudaeva,&nbsp;L S Zhigis,&nbsp;O A Razguliaeva,&nbsp;V S Zueva,&nbsp;E E Mel'nikov,&nbsp;V P Zubov,&nbsp;L V Kozlov,&nbsp;A M Bichucher,&nbsp;O V Kotel'nikova,&nbsp;A P Alliluev,&nbsp;A E Avakov,&nbsp;L D Rumsh","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A method of the isolation and purification of IgAl protease from a culture of Neisseria meningitidis serogroup A has been developed. Three inactivated intermediates of the production of the meningococcal vaccine, a culture liquid, as well as a supernatant and sediment obtained by the precipitation of bacterial cells by cetavlon, served as a starting material. The purity of IgA1 protease was determined by SDS-PAGE. An immunoenzyme assay for determining the IgA1 protease activity has been devised. The yield of the enzyme with a specific activity of 0.5 to 4 million units/mg from 103 g of the cetavlon precipitate (40 l of culture liquid) was about 600 mug. It was shown that IgAl protease isolated from serogroup A meningococcus is capable of protecting experimental animals (mice) infected with meningococcus of serogroup B.</p>","PeriodicalId":9325,"journal":{"name":"Bioorganicheskaia khimiia","volume":"36 1","pages":"89-97"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganicheskaia khimiia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A method of the isolation and purification of IgAl protease from a culture of Neisseria meningitidis serogroup A has been developed. Three inactivated intermediates of the production of the meningococcal vaccine, a culture liquid, as well as a supernatant and sediment obtained by the precipitation of bacterial cells by cetavlon, served as a starting material. The purity of IgA1 protease was determined by SDS-PAGE. An immunoenzyme assay for determining the IgA1 protease activity has been devised. The yield of the enzyme with a specific activity of 0.5 to 4 million units/mg from 103 g of the cetavlon precipitate (40 l of culture liquid) was about 600 mug. It was shown that IgAl protease isolated from serogroup A meningococcus is capable of protecting experimental animals (mice) infected with meningococcus of serogroup B.

[脑膜炎奈瑟菌IgA1蛋白酶的分离及活性测定]。
建立了一种从脑膜炎奈瑟菌血清A群培养物中分离纯化IgAl蛋白酶的方法。三种生产脑膜炎球菌疫苗的灭活中间体,一种培养液,以及由cetavlon沉淀细菌细胞获得的上清液和沉淀物,作为起始材料。用SDS-PAGE法测定IgA1蛋白酶的纯度。设计了一种测定IgA1蛋白酶活性的免疫酶测定法。从103g的cetavlon沉淀物(40l培养液)中得到比活性为50 ~ 400万单位/mg的酶,产率约为600马克。结果表明,从A群脑膜炎球菌中分离的IgAl蛋白酶对感染B群脑膜炎球菌的实验动物(小鼠)具有保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信